the Hong Kong College of Cardiology
暂无分享,去创建一个
R. Chen | P. Liu | LU Caiyi | Shiwen Wang | Xinping Du | Yinglong Hou | Qiao Xue | WU Xinli
[1] Ipen,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 2024, Heart rhythm.
[2] C. Kumana,et al. Increased adrenomedullin expression in lungs in endotoxaemia. , 2004, The Journal of endocrinology.
[3] W. Yin,et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. , 2004, American heart journal.
[4] R. Bigi,et al. Exercise versus recovery electrocardiography in predicting mortality in patients with uncomplicated myocardial infarction. , 2004, European heart journal.
[5] C. Klein,et al. Intermedin Is a Calcitonin/Calcitonin Gene-related Peptide Family Peptide Acting through the Calcitonin Receptor-like Receptor/Receptor Activity-modifying Protein Receptor Complexes* , 2004, Journal of Biological Chemistry.
[6] P. Elwood,et al. QT dispersion, QT maximum and risk of cardiac death in the Caerphilly Heart Study , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[7] H. Mori,et al. Effects of Adrenomedullin Inhalation on Hemodynamics and Exercise Capacity in Patients With Idiopathic Pulmonary Arterial Hypertension , 2004, Circulation.
[8] C. May,et al. Direct coronary vasodilator action of adrenomedullin is mediated by nitric oxide , 2003, British journal of pharmacology.
[9] K. Kitamura,et al. Plasma adrenomedullin is closely correlated with pulse wave velocity in middle-aged and elderly patients. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[10] N. Kobayashi,et al. Chronic Administration of Adrenomedullin Attenuates Transition From Left Ventricular Hypertrophy to Heart Failure in Rats , 2003, Hypertension.
[11] J. Cockcroft,et al. Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels. , 2003, British journal of clinical pharmacology.
[12] Y. Suematsu,et al. Accelerated cardiac hypertrophy and renal damage induced by angiotensin II in adrenomedullin knockout mice. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[13] E. Stabile,et al. Is Pulmonary Vein Isolation Necessary for Curing Atrial Fibrillation? , 2003, Circulation.
[14] Nader Rifai,et al. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. , 2003, Clinical chemistry.
[15] Ottavio Alfieri,et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. , 2003, Journal of the American College of Cardiology.
[16] K. Ellenbogen,et al. Ablation of atrial fibrillation: awaiting the new paradigm. , 2003, Journal of the American College of Cardiology.
[17] F. Cuttitta,et al. Adrenomedullin and cancer , 2003, Regulatory Peptides.
[18] L. Chao,et al. Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty , 2003, Regulatory Peptides.
[19] Chuncai Xue,et al. Clinical significance of serum cardiac troponin T in patients with congestive heart failure. , 2003, Chinese medical journal.
[20] H. Nishimatsu,et al. Endothelial responses of the aorta from adrenomedullin transgenic mice and knockout mice. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[21] J. Senges,et al. Catheter Ablation of Chronic Atrial Fibrillation with Noncontact Mapping: , 2003, Pacing and clinical electrophysiology : PACE.
[22] U. Ikeda,et al. Adrenomedullin expression in coronary circulation after stent implantation as a prognostic factor for restenosis , 2003, International journal of cardiovascular interventions.
[23] Y. Asada,et al. Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats. , 2002, Cardiovascular research.
[24] F. Spinale,et al. Effects of Adrenomedullin on Human Myocyte Contractile Function and β-Adrenergic Response , 2002, Journal of cardiovascular pharmacology and therapeutics.
[25] I. Chaudry,et al. Novel Approach to Prevent the Transition From the Hyperdynamic Phase to the Hypodynamic Phase of Sepsis: Role of Adrenomedullin and Adrenomedullin Binding Protein-1 , 2002, Annals of surgery.
[26] Hakan Oral,et al. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. , 2002, Journal of the American College of Cardiology.
[27] J. Alonso-Martínez,et al. C‐reactive protein as a predictor of improvement and readmission in heart failure , 2002, European journal of heart failure.
[28] J. Duarte,et al. Role of endothelium-derived relaxing factors in adrenomedullin-induced vasodilation in the rat kidney. , 2002, European journal of pharmacology.
[29] T. Eto. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides , 2001, Peptides.
[30] E Geraci,et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. , 2001, European heart journal.
[31] C. Lau,et al. Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction , 2001, Heart.
[32] U Ravens,et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. , 2001, European heart journal.
[33] M. Cleman,et al. Serum complement activation in congestive heart failure. , 2001, American heart journal.
[34] C. Rask-Madsen,et al. Prognostic value of exercise testing in a cohort of patients followed for 15 years after acute myocardial infarction. , 2001, European heart journal.
[35] A. Richards,et al. Hemodynamic, Hormone, and Urinary Effects of Adrenomedullin Infusion in Essential Hypertension , 2000, Hypertension.
[36] D. Strachan,et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. , 2000, European heart journal.
[37] J. Danesh,et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.
[38] R. Nagai,et al. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. , 2000, Circulation.
[39] J. Gardin,et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. , 2000, Journal of the American College of Cardiology.
[40] A. Richards,et al. Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. , 2000, The Journal of clinical endocrinology and metabolism.
[41] M. Leinonen,et al. Infections, inflammation, and the risk of coronary heart disease. , 2000, Circulation.
[42] M. Santacana,et al. Distribution of adrenomedullin-like immunoreactivity in the rat central nervous system by light and electron microscopy , 2000, Brain Research.
[43] S. Anker,et al. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. , 2000, International journal of cardiology.
[44] Jayne S. Truckenbrod,et al. Congestive Heart Failure , 2000, Springer New York.
[45] K. Kataoka,et al. Serial circulating concentrations of c‐reactive protein, interleukin (il)‐4, and il‐6 in patients with acute left heart decompensation , 1999, Clinical cardiology.
[46] C. Tai,et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. , 1999, Circulation.
[47] R. Nagai,et al. C-Reactive Protein in Dilated Cardiomyopathy , 1999, Cardiology.
[48] H. Kishida,et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. , 1999, The American journal of cardiology.
[49] D. Mann. Mechanisms and models in heart failure: A combinatorial approach. , 1999, Circulation.
[50] P. Wang,et al. Reduction in vascular responsiveness to adrenomedullin during sepsis. , 1999, The Journal of surgical research.
[51] J. Mair,et al. A novel biochemical approach to congestive heart failure: cardiac troponin T. , 1999, American heart journal.
[52] H. Cohen,et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.
[53] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[54] A. Döring,et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.
[55] N. Minamino,et al. Increased Plasma Concentration of Adrenomedullin in Patients with Subarachnoid Hemorrhage , 1998, Anesthesia and analgesia.
[56] S. Garrigue,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.
[57] E. Erdmann,et al. Significance of exercise-induced ST-segment elevation and T-wave pseudonormalization for improvement of function in healed Q-wave myocardial infarction. , 1998, The American journal of cardiology.
[58] Melanie G. Lee,et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.
[59] J. Potratz,et al. Relation between QT dispersion and the extent of myocardial ischemia in patients with three-vessel coronary artery disease. , 1998, The American journal of cardiology.
[60] Samsonov,et al. The activated immune system and the renin–angiotensin–aldosterone system in congestive heart failure , 1998, Journal of internal medicine.
[61] A. Harada,et al. Prognostic value of second generation cardiac troponin T in patients with chronic heart failure , 1998 .
[62] K. Werdan. The activated immune system in congestive heart failure – from dropsy to the cytokine paradigm , 1998, Journal of internal medicine.
[63] R. Bonow,et al. Chronic heart failure in the United States: a manifestation of coronary artery disease. , 1998, Circulation.
[64] R. Bigi,et al. Prognostic value of residual ischaemia assessed by exercise electrocardiography and dobutamine stress echocardiography in low-risk patients following acute myocardial infarction. , 1997, European heart journal.
[65] T. Fujita,et al. Plasma adrenomedullin in diabetes , 1997, The Lancet.
[66] B. Krämer,et al. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells. , 1997, Hypertension.
[67] G. MacGowan,et al. Circulating interleukin-6 in severe heart failure. , 1997, The American journal of cardiology.
[68] J. Burnett,et al. Role of prostaglandins and renal nerves in the renal actions of adrenomedullin. , 1997, The American journal of physiology.
[69] D. Nicholls,et al. Cytokine profile in chronic cardiac failure , 1996, European journal of clinical investigation.
[70] B. Bozkurt,et al. Basic mechanisms in heart failure: the cytokine hypothesis. , 1996, Journal of cardiac failure.
[71] K. Kitamura,et al. Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat. , 1996, Hypertension.
[72] Y. Hirata,et al. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. , 1996, The Journal of clinical endocrinology and metabolism.
[73] Y. Koiwaya,et al. Increased plasma adrenomedullin in acute myocardial infarction. , 1996, American heart journal.
[74] H. Ruskoaho,et al. Inotropic effect of adrenomedullin in the isolated perfused rat heart. , 1996, Acta physiologica Scandinavica.
[75] J. Yoshikawa,et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells , 1996, Journal of hypertension.
[76] N. Aiyar,et al. Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[77] C. May,et al. ACTH‐Suppressive and Vasodilator Actions of Adrenomedullin in Conscious Sheep , 1995, Journal of neuroendocrinology.
[78] O. Febo,et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.
[79] N. Minamino,et al. Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells , 1995, FEBS letters.
[80] J. Burnett,et al. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. , 1995, Circulation.
[81] Shokei Kim,et al. Attenuation of adrenomedullin‐induced renal vasodilatation by NG‐nitro L‐arginine but not glibenclamide , 1995, British journal of pharmacology.
[82] D. Smith,et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. , 1995, Endocrinology.
[83] N. Minamino,et al. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. , 1995, Biochemical and biophysical research communications.
[84] T. Ishimitsu,et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. , 1994, The Journal of clinical investigation.
[85] K. Kangawa,et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma , 1994, FEBS letters.
[86] Shokei Kim,et al. Effect of adrenomedullin on renal hemodynamics and functions in dogs. , 1994, European journal of pharmacology.
[87] T. Ishimitsu,et al. Genomic structure of human adrenomedullin gene. , 1994, Biochemical and biophysical research communications.
[88] K. Kangawa,et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. , 1993, European journal of pharmacology.
[89] K. Kangawa,et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. , 1993, Biochemical and biophysical research communications.
[90] S. Cobbe,et al. Study of serum C-reactive protein concentration in cardiac failure. , 1990, British heart journal.
[91] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[92] W. Samson. Adrenomedullin and the control of fluid and electrolyte homeostasis. , 1999, Annual review of physiology.
[93] Y. Yazaki,et al. Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model. , 1998, Journal of cardiovascular pharmacology.
[94] S. Bloom,et al. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. , 1997, The Journal of clinical endocrinology and metabolism.
[95] B. Cheung,et al. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. , 1997, Clinical science.
[96] Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology. , 1995, European heart journal.